SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-107956
Filing Date
2012-03-12
Accepted
2012-03-12 06:11:01
Documents
3
Period of Report
2012-04-17
Effectiveness Date
2012-03-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d293470ddef14a.htm DEF 14A 674548
2 GRAPHIC g293470g24g49.jpg GRAPHIC 7274
3 GRAPHIC g293470g71t81.jpg GRAPHIC 26167
  Complete submission text file 0001193125-12-107956.txt   721931
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33637 | Film No.: 12682318
SIC: 2834 Pharmaceutical Preparations